233 related articles for article (PubMed ID: 2411964)
1. [Clinical evaluation of CA 19-9, TPA, IAP and 5'-NPD-V as tumor markers of hepatocellular, bile duct and pancreas carcinoma].
Takahashi H; Miyazaki H; Deura M; Shimizu Y; Asukata I; Kameda H
Gan No Rinsho; 1985 May; 31(6 Suppl):623-30. PubMed ID: 2411964
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis of tumors with the use of immunologic tumor markers].
Vorlaender KO
Wien Med Wochenschr; 1983 Feb; 133(3):59-66. PubMed ID: 6189301
[No Abstract] [Full Text] [Related]
3. [Tumor markers in hepatoma, gallbladder-biliary tract and pancreas cancer].
Nakahara M; Fujisawa K
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3010-9. PubMed ID: 2445292
[TBL] [Abstract][Full Text] [Related]
4. [Tumor markers for hepatoma and carcinoma of biliary tract].
Higashino K
Rinsho Byori; 1985 Aug; 33(8):861-71. PubMed ID: 2416966
[No Abstract] [Full Text] [Related]
5. 5'-Nucleotide phosphodiesterase isozyme-V in hepatocellular carcinoma and other liver diseases.
Fujiyama S; Tsude K; Sakai M; Sato T
Hepatogastroenterology; 1990 Oct; 37(5):469-73. PubMed ID: 1701410
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of tumor markers in patients with colorectal cancer].
Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N
Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic procedures in the evaluation of hepatic diseases. Functional evaluation: carcinoembryonic antigen (CEA) and alphafetoprotein (AFP) as tumor markers of the liver.
Barroso A; Alpert E
Lab Res Methods Biol Med; 1983; 7():153-7. PubMed ID: 6194396
[No Abstract] [Full Text] [Related]
8. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer.
Ozkan H; Kaya M; Cengiz A
Hepatogastroenterology; 2003; 50(53):1669-74. PubMed ID: 14571813
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttila I
Anticancer Res; 1993; 13(5C):1883-7. PubMed ID: 8267397
[TBL] [Abstract][Full Text] [Related]
10. [Value and limitations of neoplasm markers in the diagnosis of pancreatic carcinoma].
Fabris C; Basso D; Meggiato T; Del Favero G; Fogar P; Panozzo MP; Ferrara C; Scalon P; Naccarato R
Recenti Prog Med; 1991 Mar; 82(3):166-72. PubMed ID: 2047559
[TBL] [Abstract][Full Text] [Related]
11. [Biohumeral markers in the diagnosis of pancreatic carcinoma].
Panucci A; Del Favero G; Falmis C; Brosolo P; Basso D; Pedrazzoli S; Baccaglini U; Marchioro L; Bonvilini P; Naccarato R
Recenti Prog Med; 1985; 76(7-8):385-91. PubMed ID: 3865269
[No Abstract] [Full Text] [Related]
12. Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients.
Torzilli G; Makuuchi M; Ferrero A; Takayama T; Hui AM; Abe H; Inoue K; Nakahara K
Hepatogastroenterology; 2002; 49(45):740-5. PubMed ID: 12063982
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of various tumor markers in pleural effusion and in the serum].
Jibiki K; Abe Y; Takeda M; Iwachika C; Odagiri E; Demura R; Demura H
Gan No Rinsho; 1989 Aug; 35(9):991-8. PubMed ID: 2769951
[TBL] [Abstract][Full Text] [Related]
14. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
Negishi Y; Furuno K; Sano Y; Hirata T; Utsunomiya A; Nakajima H; Okabe K; Shimizu K; Akiya K; Fujiwara Y
Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692
[TBL] [Abstract][Full Text] [Related]
15. [Tumor markers in the diagnosis of tumors in the subhepatic area].
Dufek V; Petrtýl J; Klener P; Chmel J
Vnitr Lek; 1994 Jun; 40(6):350-3. PubMed ID: 8073643
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of serum tumor markers (CEA, TPA, IAP and ferritin) in pulmonary tuberculosis].
Komatsu H
Kekkaku; 1987 Jan; 62(1):31-6. PubMed ID: 3573509
[No Abstract] [Full Text] [Related]
17. [Clinical study on tissue polypeptide antigen (TPA) as a tumor marker].
Kanauchi M; Sawai F; Saito T; Yumura F; Kanauchi K; Hamaguchi T; Hara Y; Yoshimura K; Nishiura K; Dohi K
Gan No Rinsho; 1984 Mar; 30(3):265-71. PubMed ID: 6201629
[TBL] [Abstract][Full Text] [Related]
18. Useful blood tests in the diagnosis and management of cancer: a review. Part III Antigens and Antibodies.
Hartman HA; Foley JF
Nebr Med J; 1977 Jun; 62(6):184-9. PubMed ID: 69997
[No Abstract] [Full Text] [Related]
19. [Tumor markers of pancreatic cancer].
Takami H; Hishinuma S; Shintoku J; Furuuchi T; Ogata Y; Abe O
Gan To Kagaku Ryoho; 1985 Feb; 12(2):212-9. PubMed ID: 3855615
[TBL] [Abstract][Full Text] [Related]
20. Tumor markers carbohydrate antigens CA 19-9 and CA-50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tract.
Harmenberg U; Wahren B; Wiechel KL
Cancer Res; 1988 Apr; 48(7):1985-8. PubMed ID: 3349472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
